Gandolf-Big Pharma is dying to partner to get new blockbuster drugs.
(DNAPrint has a great pipeline!)
DNAG's CD-59 is also has huge potential and CD-59 does have interested parties....
2 diagnostic co's
(Per Richard's webcast...)
And Tony's SNips to tell drug toxicity..
DNAPrint has a lot to partner with.
At worst case....
Bridge loan?
Put the company up for sale?
But, I think the direction is spin off DNAPrint Pharm and DNAG would retain a large portion of those shares.
DNAG, in my opinion has a lot of possibilities! (I believe DNAPrint would just sell out and not go bankrupt.)
MY GUESS..We would get well over .01 for our shares because all of management options are at .01.
More like .05 or better, but I believe that the company has VALUE!
Market Data 
Markets 
AI
